With the global aging and obese population skyrocketing increasing these years, skeletal disorders including osteoporosis and osteoarthritis jeopardize the motor ability of millions worldwide. In vitro models that can reliably predict the efficacy of disease-modifying osteoarthritis drugs are prevailingly needed. Here, Creative Biolabs offers a newly developed microphysiological cartilage-on-a-chip model that enables the application of strain-controlled compression to three-dimensional articular cartilage microtissue.
Our cartilage-on-a-chip model consists of a top cell culture chamber in which a 3D cell-laden hydrogel is confined by two rows of overhanging posts in a miniaturized rectangular channel. This chamber lies on a membrane covering a pneumatic chamber. As the pressure in the pneumatic chamber increases, the membrane bends upward and compresses the hydrogel while the hanging posts limit the lateral expansion. 3D macroscale systems integrating cells, soluble factors, and extracellular matrix-like matrices have been used to model articular cartilage, recapitulating both cellular-specific architecture and the mechanical environment.
Fig.1 Schematic description of the bone/cartilage organoid on-chip. (Hu, 2023)
Current in vitro models also rely on biochemical (cytokine-based) or mechanical (load-based) stimulation. However, it is obvious to conclude their pros and cons as charted follows:
Comparisons of Current In Vitro Cartilage-on-a-chip Models | ||
Cytokine-based Models | Induce a downstream effect | |
Need for supraphysiological doses of biochemical stimuli | ||
Load-based Models | Recapitulating the actual articular cartilage environment found in vivo | |
Hold the potentiality of triggering a response without the need for supraphysiological doses of biochemical stimuli | ||
Instrumental in defining a background on the mechanism involved in the pathological load response | ||
Fail in finely tuning the stimuli provided to the tissue and thus capturing the native joint physiological/pathological environment | ||
Cannot account for pathophysiological levels of compression | ||
Cartilage-on-a-chip Models | More effective than other ex vivo and in vitro models that rely on single stimuli such as a pro-inflammatory cytokine | |
Making it possible to observe a whole constellation of responses and network interactions involved in promoting the inflammatory response in cartilage | ||
Enabling the development of a "joint-on-a-chip" and pushing the development of high-throughput use |
Creative Biolabs' novel platform to recapitulate the physiological condition and pathological changes in bone and joints is now urgently needed. Our cartilage-on-a-chip model has crossed the barrier between ex-vivo cell culture, animal models, and the real pathological status in human bodies and possesses multiple variables that could demonstrate pathophysiology characteristics during cartilage disorders. We are happy to share new opportunities for you in terms of drug screening and therapeutic resolutions in cartilage studies.
Explore our website for the organ-on-a-chip models you need:
Creative Biolabs is focused on delivering reliable services and premium organ-on-a-chip models to a worldwide audience. In addition to our comprehensive model selection, we have successfully established an advanced 3D biology-based assay platform including the correlated services listed below, to accelerate the development of preclinical drug discovery. For any professional technical support you seek, do not hesitate to contact us at your convenience.
References